Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations Aug 29, 2024
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel Aug 28, 2024
Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow Aug 22, 2024
Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel Aug 22, 2024
Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family Aug 13, 2024
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel Jul 23, 2024
